Autologous stem-cell transplantation
||It has been suggested that this article be merged into Hematopoietic stem cell transplantation. (Discuss) Proposed since November 2016.|
||This article includes a list of references, related reading or external links, but its sources remain unclear because it lacks inline citations. (December 2015) (Learn how and when to remove this template message)|
Autologous stem-cell transplantation (also called autogenous, autogeneic, or autogenic stem-cell transplantation and abbreviated auto-SCT) is autologous transplantation of stem cells—that is, transplantation in which stem cells (undifferentiated cells from which other cell types develop) are removed from a person, stored, and later given back to that same person. Although it is most frequently performed with hematopoietic stem cells (precursors of blood-forming cells) in hematopoietic stem cell transplantation, cardiac cells have also been used successfully to repair damage caused by heart attacks.
Autologous stem-cell transplantation is distinguished from allogenic stem cell transplantation where the donor and the recipient of the stem cells are different people.
- "What Are Stem Cells?". Retrieved 2017-02-12.
- Autologous stem-cell transplantation entry in the public domain NCI Dictionary of Cancer Terms
- ScienceDaily Report University of Louisville. "Two years out, patients receiving stem cell therapy show sustained heart function improvement, study suggests." ScienceDaily, 6 Nov. 2012. Web. 6 Nov. 2012.
|This medical treatment–related article is a stub. You can help Wikipedia by expanding it.|